
|Articles|July 6, 2023
Illuminating the Cellular and Molecular Response to Drug Treatment by Combining Bioenergetic Measurements with Untargeted Metabolomics
Author(s)Agilent Technologies, Inc.
This poster exhibits how combining XF and LC/MS technologies can provide deeper insight into the cellular and molecular metabolic response to drug treatment for cancer research.
